Morgan Stanley Pure Tech Health PLC Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTC
# of Institutions
7Shares Held
322KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC302KShares$5.89 Million0.37% of portfolio
-
Pentwater Capital Management LP Naples, FL16.2KShares$315,9250.01% of portfolio
-
Adar1 Capital Management, LLC Austin, TX700Shares$13,6570.0% of portfolio
-
Ubs Group Ag351Shares$6,8480.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY73Shares$1,4240.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $544M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...